Disease | c syndrome |
Phenotype | C0022658|renal diseases |
Sentences | 2 |
PubMedID- 24744899 | Further, increasing adiponectin levels by targeting the action of ang ii may be a logical and promising approach for the treatment of cardiovascular and renal diseases associated with metabolic syndrome or diabetes. |
PubMedID- 22532116 | This review focuses on the importance of the transcription factors peroxisome proliferator-activated receptor alpha, peroxisome proliferator-activated receptor beta, peroxisome proliferator-activated receptor gamma, liver x receptors, farnesoid x receptor, and the pregnane x receptor/steroid and xenobiotic receptor (pxr) on the physiology and pathophysiology of renal diseases associated with obesity and metabolic syndrome. |
Page: 1